Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.
Patterns of somatic mutations in cancer genes provide information about their functional role in tumourigenesis, and thus indicate their potential for therapeutic exploitation. Yet, the classical distinction between oncogene and tumour suppressor may not always apply. For instance, TP53 has been sim...
Main Authors: | Barbara Mair, Tomasz Konopka, Claudia Kerzendorfer, Katia Sleiman, Sejla Salic, Violeta Serra, Markus K Muellner, Vasiliki Theodorou, Sebastian M B Nijman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-09-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5010247?pdf=render |
Similar Items
-
GATA5 loss-of-Function Mutations Underlie Tetralogy of Fallot
by: Dong Wei, Han Bao, Xing-Yuan Liu, Ning Zhou, Qian Wang, Ruo-Gu Li, Ying-Jia Xu, Yi-Qing Yang
Published: (2013-01-01) -
MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
by: Michal Smida, et al.
Published: (2016-12-01) -
Novel GATA5 loss-of-function mutations underlie familial atrial fibrillation
by: Jian-Yun Gu, et al.
Published: (2012-12-01) -
GATA-Assistenten – En konceptvalidering av röststyrning i GATA
by: Yürek, Markus
Published: (2019) -
GATA2 mutations and overexpression in pediatric acute myeloid leukemia
by: Zhenzhen Yang, et al.
Published: (2019-08-01)